People first*

Diabeloop partners with patients: Since its creation, Diabeloop has been involving people living with Type 1 diabetes and their families. They have contributed to the development  alongside engineers and healthcare professionals. 

The ease of use and intuitive interfaces of personalized solutions developed by Diabeloop are really inspired by patients and their personal experiences. 

icon Created with Sketch.

The international launch of an independant young company

In November 2018, Diabeloop’s first medical device was CE marked. We are working on commercializing, in Europe (France and Germany at first) and later in North America. 

To support our international ambition and our Research and Development roadmap, we completed a Series B round of funding, setting a European fundraising record for therapeutic artificial intelligence.

icon Created with Sketch.

Reduce the heavy burden for people with diabetes

Diabeloop developed a self-learning algorithm that embeds therapeutic artificial intelligence, to automate Type 1 diabetes treatment. It is intended to relieve people affected by this chronic condition from having to make constant therapeutic decisions every day and night, and to allow them to live life without interruptions.

icon Created with Sketch.

The magazine presents Diabeloop's closed-loop system for autonomous T1D management

https://www.eu-startups.com/2019/11/diabeloop-the-french-startup-innovating-for-autonomous-diabetes-management/

Announcement of Diabeloop's first international brand campaign "Rock Your Diabetes" in a communication-related media

Exclusive interview of Marc Julien, Diabeloop co-CEO, in French financial daily to announce the Series B round of funding of 31 million euros, concluded at the end of 2019

The digital health publication covers the record breaking Series B round of funding, completed by Diabeloop in the area of therapeutic artificial intelligence

https://www.mobihealthnews.com/news/europe/french-startup-diabeloop-announces-31m-series-b-funding-round

Interview with Marc Julien, Diabeloop co-CEO. Overview of the DBLG1, the automated insulin delivery system developed by Diabeloop, company milestones...

https://biotuesdays.com/2020/03/10/diabeloop-bringing-innovation-to-type-1-diabetes-patients/?utm_source=rss&utm_medium=rss&utm_campaign=diabeloop-bringing-innovation-to-type-1-diabetes-patients

Awards

French Tech 120

Start Up of the Year 2019 award

InnovEIT Award 2019

Awarding fundings in 2016-2017 and 2018-2019

Trophée de l'Embarqué, Health Award

Born Global Award Start-up of the Year EY 2018

Jury Prize, Start-up of the Year SNITEM

Samsung Artificial Intelligence Award Vivatech 2018